Villere ST Denis J & Co. LLC Has $33.88 Million Holdings in Teleflex Incorporated (NYSE:TFX)

Villere ST Denis J & Co. LLC decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 21.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 136,980 shares of the medical technology company's stock after selling 37,878 shares during the quarter. Teleflex makes up approximately 2.8% of Villere ST Denis J & Co. LLC's holdings, making the stock its 13th biggest holding. Villere ST Denis J & Co. LLC owned 0.29% of Teleflex worth $33,878,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of TFX. Oregon Public Employees Retirement Fund boosted its holdings in shares of Teleflex by 1.2% during the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company's stock valued at $846,000 after acquiring an additional 46 shares during the period. Cromwell Holdings LLC increased its stake in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after buying an additional 49 shares during the period. Crossmark Global Holdings Inc. raised its position in shares of Teleflex by 1.9% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company's stock worth $584,000 after buying an additional 53 shares in the last quarter. Empirical Finance LLC raised its position in shares of Teleflex by 3.9% during the 1st quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company's stock worth $354,000 after buying an additional 58 shares in the last quarter. Finally, SRS Capital Advisors Inc. lifted its stake in shares of Teleflex by 0.3% in the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company's stock worth $4,107,000 after acquiring an additional 62 shares during the period. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Down 1.3 %

TFX traded down $2.48 during midday trading on Friday, hitting $195.55. 645,597 shares of the company's stock traded hands, compared to its average volume of 376,977. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a market cap of $9.08 billion, a PE ratio of 38.88, a price-to-earnings-growth ratio of 2.07 and a beta of 1.18. The stock's fifty day simple moving average is $235.39 and its 200-day simple moving average is $223.70. Teleflex Incorporated has a one year low of $194.58 and a one year high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter last year, the firm earned $3.64 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's payout ratio is 27.04%.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of research reports. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Truist Financial restated a "hold" rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Friday, November 1st. Stephens raised their price objective on Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $259.25.

Insider Buying and Selling

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total transaction of $638,898.82. Following the transaction, the director now owns 5,496 shares in the company, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.43% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.